Amy Rhee

Amy Rhee is a Senior Manager Regulatory Affairs CMC at Amgen Inc. Her technical knowledge, ranging from molecular biology to downstream purification to drug product fill and finish prepared her for her current role as a global product lead in RA CMC lifecycle management and global strategy development. She received her BA from Washington University at St. Louis and a MS in RNA Molecular Biology from Case Western Reserve University. Prior to landing in regulatory, she held various positions in academic labs, in Drug Substance Process Development at Fraunhofer Center for Molecular Biotechnology and in Drug Product Process Development at Amgen.